Rigel Pharmaceuticals (NASDAQ:RIGL) traded at $1.05 at close of the session on Tuesday, April 30, made a downward move of -1.87% on its previous day’s price.
Looking at the stock we see that its previous close was $1.07 . In terms of its 52-week price range, RIGL has a high of $1.96 and a low of $0.71. The company’s stock has lost about -21.64% over that past 30 days.
Rigel Pharmaceuticals has a market cap of $184.15 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.03, with the EPS growth for the year raised at -$0.06 for 2024 and $0.09 for next year. These figures represent 57.10% and 250.00% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $31.28 million, with a low of $30.17 million and a high of $32.9 million. The median projection represents growth squeezing down to 20.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $148.99 million, or 27.50% up from figures reported last year.
On the other hand, looking at the outlook for the RIGL stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -11.00% off its SMA20 and -20.58% from its 50-day simple moving average. The RSI (14) is pointing at 30.71 while the volatility over the past week is 6.21% and jumps to 5.78% over the past one month. The beta value is 1.03, while the average true range (ATR) is currently pointing at 0.07.
Coming back to Rigel Pharmaceuticals (NASDAQ:RIGL), we note that the average 3-month trading volume was 1.49 million. Current shares outstanding are 174.83 million.
The insiders hold 1.96% of the company’s shares while institutions hold 60.88%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -27.59% down in year-to-date price movement.
